Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive
Is ATA188 effective as a therapy for those with progressive multiple sclerosis?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
The purpose of this study is to evaluate the safety and tolerability of ATA188 as
monotherapy in Parts 1 and 2, to determine the recommended Part 2 dose (RP2D) of ATA188
monotherapy in Part 1, and to evaluate the effect of ATA188 treatment on clinical
as assessed by sustained Expanded Disability Status Scale (EDSS) improvement at 12
Part 2 in participants with progressive forms of multiple sclerosis (MS) (primary
multiple sclerosis [PPMS] and secondary progressive multiple sclerosis [SPMS]).
Study Reference #: 00005559
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Jennifer Voelkl
Phone: (585) 276-3513
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search